From natural products to achiral drug prototypes: Potent thrombin inhibitors based on P2/P3 dihydropyrid-2-one core motifs

被引:10
|
作者
Hanessian, Stephen [1 ]
Therrien, Eric [1 ]
Zhang, Jianbin [1 ]
van Otterlo, Willem [1 ]
Xue, Yafeng [2 ]
Gustafsson, David [3 ]
Nilsson, Ingemar [4 ]
Fjellstrom, Ola [5 ]
机构
[1] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada
[2] AstraZeneca R&D, Cell Prot & Struct Sci, S-43183 Molndal, Sweden
[3] AstraZeneca R&D, Sci Advisory Grp, S-43183 Molndal, Sweden
[4] AstraZeneca R&D, Med Chem, S-43183 Molndal, Sweden
[5] AstraZeneca R&D, Lead Generat, S-43183 Molndal, Sweden
基金
加拿大自然科学与工程研究理事会;
关键词
Thrombin inhibitors; Dihydropyridone; STRUCTURAL CONFIRMATION; BLOOD-COAGULATION; DESIGN; ANTICOAGULANT; DYSINOSIN; ACETAMIDE; PROGRESS; FAMILY;
D O I
10.1016/j.bmcl.2009.07.107
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of dihydropyrid-2-ones was synthesized and tested for inhibitory activity against serine protease enzymes. Moderate to low nanomolar inhibitory activities were obtained against thrombin and excellent selectivity against trypsin was observed. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5429 / 5432
页数:4
相关论文
共 2 条
  • [1] P2-P1′ macrocyclization of P2 phenylglycine based HCV NS3 protease inhibitors using ring-closing metathesis
    Lampa, Anna
    Ehrenberg, Angelica E.
    Vema, Aparna
    Akerblom, Eva
    Lindeberg, Gunnar
    Danielson, U. Helena
    Karlen, Anders
    Sandstrom, Anja
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (16) : 4917 - 4927
  • [2] Identification of Highly Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors against Lopinavir and Darunavir Resistant Viruses from Allophenylnorstatine-Based Peptidomimetics with P2 Tetrahydrofuranylglycine
    Hidaka, Koushi
    Kimura, Tooru
    Sankaranarayanan, Rajesh
    Wan, Jun
    McDaniel, Keith F.
    Kempf, Dale J.
    Kameoka, Masanori
    Adachi, Motoyasu
    Kuroki, Ryota
    Nguyen, Jeffrey-Tri
    Hayashi, Yoshio
    Kiso, Yoshiaki
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (12) : 5138 - 5153